Ac Immune Sa
Clinical trials sponsored by Ac Immune Sa, explained in plain language.
-
New vaccine trial targets Alzheimer's in High-Risk groups
Disease control Recruiting nowThis study is testing an investigational vaccine called ACI-24.060 to see if it is safe and can help the body's immune system fight the harmful amyloid proteins linked to Alzheimer's disease. It is enrolling 176 adults who either have very early-stage Alzheimer's (prodromal) or a…
Phase: PHASE1, PHASE2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test 'Flashlight' scan to see Parkinson's brain clumps
Diagnosis Recruiting nowThis early-stage study is testing a new type of brain scan to see if it can safely and reliably detect clumps of a protein called alpha-synuclein in the brain. These protein clumps are involved in Parkinson's disease, Lewy body dementia, and multiple system atrophy. Researchers w…
Phase: EARLY_PHASE1 • Sponsor: AC Immune SA • Aim: Diagnosis
Last updated Apr 01, 2026 23:26 UTC
-
First human tests begin for experimental brain drug
Knowledge-focused Recruiting nowThis is a first-in-human study to check the safety and tolerability of a new drug called ACI-19764, which is designed to target the brain. It will involve 78 healthy volunteers to see how the body absorbs and processes the drug at different dose levels. The main goal is to gather…
Phase: PHASE1 • Sponsor: AC Immune SA • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC